Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to ...

Kimberly-Clark is buying Tylenol maker Kenvue for nearly $50 billion. Wall Street isn’t too fond of the deal—for good reason.

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

Kimberly-Clark will buy Kenvue for $48.7 billion. Kenvue is the maker of Tylenol. Kenvue just beat earnings in its Q3 2025 ...

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...